Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Frontiers in Endocrinology, 2025
Proximity extension assay revealed novel inflammatory biomarkers for follicular development and ovarian function: a prospective controlled study combining serum and follicular fluid

Wang C., Feng Y., Chen Y. et al.

Olink Target 96ObstetricsPatient StratificationSerumFollicular Fluid

Journal of Stroke and Cerebrovascular Diseases, 2025
Exploring the bidirectional relationships between alzheimer's disease and cerebral small vessel disease: Insights from mendelian randomization

Shang H., Liu T., Gong W. et al.

Olink Target 96CVDNeurologyPathophysiologyPlasma

Brain Communications, 2025
An open-label Phase 2a study to assess the safety and tolerability of trimetazidine in patients with amyotrophic lateral sclerosis

van Eijk R., Steyn F., Janse van Mantgem M. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Arthritis Research & Therapy, 2025
Integrated analysis of dermatomyositis reveals heterogeneous immune infiltration and interstitial lung disease-associated endotype

Xu X., Qiu T., Sun K. et al.

Olink Target 96Respiratory DiseasesImmunological & Inflammatory DiseasesPathophysiologyPatient StratificationSerum

International Journal of Chronic Obstructive Pulmonary Disease, 2025
The Mediation of Circulating Inflammatory Proteins in the Causal Pathway from Immune Cells to COPD

Yan K., Wang Y., Xin P.

Olink Target 96Respiratory DiseasesPathophysiologyPlasma

Movement Disorders, 2025
Effects of Montelukast on Neuroinflammation in Parkinson's Disease: An Open Label Safety and Tolerability Trial with CSF Markers and [11C]PBR28 PET

Wallin J., Forsberg A., Svenningsson P.

Olink Target 96NeurologyPathophysiologyPlasmaCSF

ImmunoTargets and Therapy, 2025
Genetic and Plasma Proteomic Approaches to Identify Therapeutic Targets for Graves’ Disease and Graves’ Ophthalmopathy

Ke C., Yu Y., Li J. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesOphthalmologyPathophysiologyPlasma

Journal for ImmunoTherapy of Cancer, 2025
Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights

Wang X., Tian H., Chi Z. et al.

Olink Target 96OncologyImmunotherapyPathophysiologySerum

eBioMedicine, 2025
Cardio-metabolic-related plasma proteins reveal biological links between cardiovascular diseases and fragility fractures: a cohort and Mendelian randomisation investigation

Michaëlsson K., Zheng R., Baron J. et al.

Olink Target 96Olink Explore 3072/384CVDAgingPathophysiologyPatient StratificationPlasma

Nature Cardiovascular Research, 2025
Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction

Rasooly D., Giambartolomei C., Peloso G. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Translational Vision Science & Technology, 2025
Genetics of Circulating Inflammatory Proteins and Iridocyclitis: An Exploratory Mendelian Randomization Study

Liu H., Li F., Wang F. et al.

Olink Target 96Immunological & Inflammatory DiseasesOphthalmologyPathophysiologyPlasma

Nature, 2025
A neoantigen vaccine generates antitumour immunity in renal cell carcinoma

Braun D., Moranzoni G., Chea V. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

Cell Death Discovery, 2025
Pan-caspase inhibitors induce secretion of HIV-1 latency reversal agent lymphotoxin-alpha from cytokine-primed NK cells

Hajikhezri Z., Zygouras I., Sönnerborg A. et al.

Olink Explore 3072/384Infectious DiseasesPathophysiologyCell Culture Supernatant

Scientific Reports, 2025
Untargeted metabolomic and proteomic analysis implicates SIRT2 as a novel therapeutic target for diabetic nephropathy

Zhang R., Chang R., Wang H. et al.

Olink Target 96Metabolic DiseasesNephrologyPathophysiologySerum

Journal of Proteome Research, 2025
Serum Immune-Response Protein Biomarkers Based on Olink Technology for Diagnosis of Ischemic Stroke

Wang H., Zhao T., Zeng J. et al.

Olink Target 96NeurologyPatient StratificationPlasma

Journal of Ethnopharmacology, 2025
Lianhua Qingke Tablet in severe pneumonia: Clinical efficacy and immunoregulatory mechanisms

Jin P., Qi H., Zhao J. et al.

Olink Target 96 MouseRespiratory DiseasesPathophysiologyMouse Tissue Lysate

Journal of Translational Medicine, 2025
Multi-omics dissection of metabolic dysregulation associated with immune recovery in people living with HIV-1

Wan L., Lam S., Huang H. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

Clinical Cancer Research, 2025
Corticosteroid-Dependent Association between Prognostic Peripheral Blood Cell-Free DNA Levels and Neutrophil-Mediated NETosis in Patients with Glioblastoma

Till J., Seewald N., Yazdani Z. et al.

Olink Target 96OncologyPatient StratificationPlasma

Molecular Neurobiology, 2025
Prospective Investigation Unravels Plasma Proteomic Links to Dementia

Li J., Li J., Chen S. et al.

Olink Explore 3072/384NeurologyPathophysiologyPatient StratificationPlasma

Rheumatology, 2025
Plasma proteomics for risk prediction and identification of novel drug targets in systemic lupus erythematosus

Yang S., Zhang Y., Ye Z. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPatient StratificationPlasma

2965 publications